SHAREHOLDERS' EQUITY

3 Months Ended

Mar. 31, 2022

Stockholders' Equity Note [Abstract]

SHAREHOLDERS’ EQUITY

SHAREHOLDERS’ EQUITY

Dividend Equivalents

The following table presents the amounts accrued and unpaid dividends on unvested RSUs as of the dates indicated:

		Dividend Equivalent Liabilities
	Balance Sheet Location	March 31, 2022		December 31, 2021
		(amounts in thousands)
Short-term	Other current liabilities	$	240	$	351
Long-term	Other long-term liabilities	1		92
Total		$	241	$	443

Employee Stock Purchase Plan

Following the purchase of shares under the ESPP for the first quarter of 2020, the Company temporarily suspended the ESPP. The ESPP resumed on July 1, 2021. The following table presents the amount of shares purchased and non-cash compensation expense recognized in connection with the ESPP as of the periods indicated:

	Three Months Ended March 31,
	2022		2021
	(amounts in thousands)
Number of shares purchased	61		—
Non-cash compensation expense recognized	$	26	$	—

Share Repurchase Program

During the three months ended March 31, 2022, the Company did not repurchase any shares under the 2017 Share Repurchase Program. As of March 31, 2022, $41.6 million is available for future share repurchases under the 2017 Share Repurchase Program.

Shareholder Rights Agreement

On April 20, 2020, the Company entered into a Rights Agreement between the Company and American Stock Transfer & Trust Company, LLC, as Rights Agent (as amended from time to time, the "Rights Agreement"), which was previously approved by the Board of Directors of the Company (the "Board of Directors").

The Rights Agreement expired on April 20, 2021.